Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study

Research output: Contribution to conferenceOtherpeer-review

Original languageEnglish
Pagese12552-e12552
Number of pages1
Publication statusPublished - 2017

Cite this